Eric Rougemond
Chief Executive Officer
Clinical Biology
Px Therapeutics
France
Biography
Eric Rougemond, currently CEO of Laboratoire Aguettant, was appointed CEO of PX'Therapeutics in June 2013. Eric is a Doctor of Medicine, specialised in Clinical Biology. He was formerly the General Manager (France) and VP of EUSA Pharma. Prior to taking up his position at PX'Therapeutics, he served as Medical Director at Merck KGaA and OPi. Eric brings to PX'Therapeutics extensive experience in the life-sciences industry and the ambition to strengthen PX'Therapeutics’ position as one of the leading European mid-size Contract Development and Manufacturing Organisations.
Research Interest
Clinical Biology
